GET THE APP

An overview on sleep apnoea in Polycystic ovary syndrome | 19972
Endocrinology & Metabolic Syndrome

Endocrinology & Metabolic Syndrome
Open Access

ISSN: 2161-1017

+44 1478 350008

An overview on sleep apnoea in Polycystic ovary syndrome


4th World Congress on Polycystic Ovarian Syndrome

October 26-27, 2018 | Boston, USA

Khulud Nazer

Royal Hallamshire University Hospital- Sheffield, United Kingdom

Scientific Tracks Abstracts: Endocrinol Metab Syndr

Abstract :

Many women with PCOS are obese and have a higher prevalence of impaired glucose tolerance, type II diabetes and sleep apnoea than is observed in the general population. They exhibit an adverse cardiovascular risk profile, characteristic of the cardiometabolic syndrome as suggested by a higher reported incidence of hypertension, dyslipidemia, visceral obesity, insulin resistance, and hyperinsulinemia. The definition of Obstructive Sleep Apnoea OSA, pathophysiology and causes will be presented. Research has shown that raised BMI women with PCOS will have higher rates of OSA for the same BMI group compared to women without PCOS. Theories behind that will be covered together with a possible treatment strategy.

Biography :

Khulud Nazer graduated from Jordan University Hospital in 1995. She has the Jordanian Board in ENT and worked as a Specialist in ENT in Amman. She has worked in Royal Blackburn Hospital and Manchester Royal Infirmary. She has an interest in Medical Education, Aesthetic Medicine and Otology. At present, she is a specialty Doctor Fellow in the ENT and Balance unit in Royal Hallamshire Hospital in Sheffield-UK.

E-mail: knazer@btinternet.com

 

Top